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Abstract 
Osteoporosis is noted as one of the foremost causes of disability and morbidity worldwide (Rapp 
et al., 2016).  An osteoporotic fracture can result in significant debility, resulting in significant 
financial burdens. Screening guidelines for osteoporosis are in place, but confounding variables 
often lead to missed screening and treatment opportunities. Xu, Lombardi, Jiao, and Banfi  
(2016) state that bone health is essential for maintaining quality of life and overall health and that 
one out of two Caucasian women will suffer an osteoporotic-related fracture in her lifetime. 
Current research supports identifying those at risk, screening, and potentially implementing 
pharmacological treatment regimens to increase bone density once osteoporosis is diagnosed. 
Numerous screening instruments are available to identify those at risk, but many women are 
under-screened for this potentially debilitating disease. The purpose of this Doctor of Nursing 
Practice (DNP) translational project is to determine if the implementation of an osteoporotic 
fracture prevention workshop for Advanced Practice Registered Nurses (APRNs) impacts 
screening practice patterns for perimenopausal female patients.  
Keywords: Osteoporosis, osteoporosis screenings, fragility fracture, bone density 
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Implementation of an Osteoporosis Workshop for APRN’s to Identify Female Patients at Risk 
for Low Bone Mass 
      Osteoporosis is a bone disease characterized by low bone mass and deterioration of 
skeletal bone tissue which often results in increased bone fragility and fracture (Black, Reid, & 
Sandison, 2009). It is a common skeletal condition that is prevalent amongst postmenopausal 
females when estrogen storage and production drops significantly. It is often referred to as the 
silent disease and not detected until an osteoporotic fracture occurs, often preceded by a fall. 
These fragility fractures are one of the leading causes of disability for the older population (Rapp 
et al., 2016). A fragility fracture increases the risk of a subsequent fracture by 50% (Mendis, 
Ganda, & Seibel, 2017). Age related bodily changes often affect numerous bodily systems which 
includes decrease in sensory perception, decreased body mass, changes in visual acuity, and 
neuro related conditions causing imbalance. Low bone mass (osteopenia or osteoporosis), 
decreased vision acuity, and falls can perpetrate fractures that increase morbidity and mortality. 
The impact of osteoporosis affects 200 million women worldwide with over nine million 
fractures per year in the United States (Keshishian et al., 2017). The impact of direct medical 
costs following a fragility fracture is estimated at $17 billion in Canada (Weng, Hess, Lynn, & 
Litner, 2015) and $20 billion in the United States (U.S.) per year (Shuler, Scott, Wilson-Byrne, 
Morgan, & Olajide, 2016). Xu et al. (2016) state the likelihood of a woman experiencing an 
osteoporotic-related fracture in her lifetime is one out of two women. It is estimated that 10%-
20% of hip fracture patients die within the first year after the related fall/injury and risk of 
premature death is elevated for at least 10 years (Gillespie & Morin, 2016). The impact, burden, 
rehabilitation, and costs associated with these fractures are significant and often result in 
permanent residence in an assisted living or skilled care living institution. The prevalence of 
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osteoporosis is expected to climb as our population increases and ages. Evidence-based 
guidelines for low bone mass screening and treatment are readily available, however research 
reveals that osteoporosis remains under-diagnosed, under-screened, and under-treated, especially 
in the non-Caucasian population (Golob & Laya, 2015). 
Evidence-based screening tools are noted to be one of the most beneficial and reliable 
ways to diagnose those at risk not only for osteoporosis but for current low bone mass and 
density. However, it is estimated that millions of women are under screened for this serious 
disease and providers lack consistency with their screening protocols. This translational project 
seeks to explore if the implementation of an osteoporotic fracture prevention workshop will 
impact and/or change pre-screening patterns by APRN’s for their female patients ages 45-64. 
Background 
Bone balance is determined by the activity of osteoclasts (break down bone tissue) and 
osteoblasts (build new bone tissue). Well known major risk factors for the development of 
osteoporosis include: female gender, advancing age, and estrogen deficiency. There are many 
other risks that increase one’s risk for bone loss. Behavioral risks include: excess alcohol intake, 
inadequate calcium and Vitamin D intake, tobacco abuse, lack of exercise, and diet (Golob & 
Laya, 2015). Other risks include demographic factors such as race, height and body habitus, and 
medical conditions such as rheumatoid arthritis, hypogonadal disorders, and 
hyperparathyroidism. Medications, such as glucocorticoids, are attributed with significant risk 
for bone loss especially during the first few months of use (Golob & Laya, 2015).  
Prevention is a vital component in identifying those at risk or deemed a future risk for an 
osteoporotic fracture. Recent studies identified by Xu et al. (2016) have shown that screening 
rates for Medicare age women are as low as 30-48% over a seven-year time frame. The United 
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States Preventive Services Task Force (USPSTF) has recommended universal osteoporosis 
screening for women 65 years and older (at 2-year intervals), and targeted screenings for 
younger women with identified risk factors (United States Preventive Services Task Force, 2018) 
with a dual energy x-ray absorptiometry scan (DXA). Other reputable guidelines exist for the 
U.S. and include those of the National Osteoporosis Foundation (NOF) (Siris et al., 2014)  and 
World Health Organization (WHO) (World Health Organization-4bonehealth, n.d.). In 2008 
newer WHO screening guidelines were established based on fracture risk and served as a model 
for lowering the risk with use of osteoporosis medicines. The new guidelines for treatment are 
for postmenopausal women, any ethnicity or race, and for men age 50 and over (World Health 
Organization-4bonehealth, n.d.). Three categories were specified as high risk groups and met the 
Food and Drug Administration (FDA) criteria for FDA approved drug implementation. The three 
groups include those with (1) a history of fracture of the hip or spine (2) those with a bone 
mineral density (BMD) in the osteoporosis range (T-score of -2.5 or lower), and (3) those with a 
BMD in the low bone mass or osteopenia range with a higher risk of fracture defined by the 
fracture risk assessment tool (FRAX)  score for a major osteoporotic fracture 10-year probability 
of 20% or higher or a hip fracture 10-year probability 3% or higher.  
 APRNs play a vital role in the prevention and screening aspect of healthcare. Patients 
often choose to see an APRN to provide comprehensive primary care which includes 
preventative counseling and recommended screenings. Once osteoporosis is diagnosed by a 
provider, bone mass loss can often be reversed by diet, exercise, vitamin supplementation, and 
pharmacologic therapy. However, studies indicate low screening rates for women ages 50 and 
greater in the U.S. from 2008-2014 (Gillespie & Morin, 2016) with screening among women 
ages 50-64 years dropping steadily. Gillespie and Morin (2016) state that recent studies indicate 
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screening rates state that recent studies indicate screening rates were low with the average 
screening rate for women ages 50-64 only 21.1% and 26.5% for ages 65-79.  
Problem Statement 
Prevention of osteoporosis should be of prudent concern for health care providers 
because most women are not screened routinely. The goal of osteoporosis screening is to identify 
those women at increased risk of low bone mass and possible future fracture who would benefit 
from an intervention such as medication administration to decrease that risk (Jiang et al., 2016). 
Numerous non-radiologic risk assessment tools exist for screenings such as the FRAX Tool 
which uses multiple risk factors that can be used with or without a BMD to predict the 10-year 
probability of a hip fracture or other major osteoporotic fractures (Chen et al., 2016). The Simple 
Calculated Risk Estimation tool (SCORE) (Appendix A) is based on race, age, weight, previous 
fracture, history of autoimmune disease and use of estrogen therapy (University of Washington-
Osteo ED, n.d.). This non-invasive and non-radiologic screening tool can play a key role in 
identifying those younger individuals at risk for low bone mass. Recent data indicates that less 
than one in four privately insured women (65+ years) are screened for primary prevention by 
their healthcare provider (Gillespie & Morin, 2016) and younger women, less than 65 with 
known risk factors, are not screened until well after a fracture occurs. Numerous FDA approved 
osteoporotic drugs are available and have been shown to reduce the risk of fractures by 20-50% 
(Elders et al., 2017). Inconsistent screenings can lead to potentially disabling fractures, undue 
pain, rehabilitation, significant medical bills, relocation to assisted living or skilled living 
facilities, increased mortality, and possible mortality (Black, Reid, & Sandison, 2009). 
Coordination of care and screenings are often managed between numerous providers and 
specialists which unintentionally creates a gap that assumes screenings are being managed by 
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others. There are numerous barriers that exist in implementing these guidelines which include 
knowledge, time, insurance challenges, and financial barriers. A recent interview with Debby 
Godwin, a nurse practitioner (NP) in a family practice setting, illustrated her confusion with 
osteoporosis screenings (D. Godwin, personal communication, October 12, 2018). She reflected 
she should be utilizing the screening tools more efficiently but time restraints in a busy setting 
often negate the tool being used. Debbie also stated that denials for DXA scans were a great 
concern for females under age 65 and are often not covered by the insurance companies-so 
females often lack screenings.  
Needs Assessment 
Gillespie and Moran (2017) state that screening rates for osteoporosis in women between 
the ages of 55 and 64 decreased by 44% and non-Hispanic women were least likely to be 
screened. This study concluded only 21% of women (age 55-64) were screened for osteoporosis 
and screening rates were low for women  >65 years of age. The USPSTF has specific guidelines 
in place stating osteoporosis screening should begin at age 65 or for those with identifiable risk 
factors. Mortality rates post hip fracture are 20-25% (Rapp et al., 2016) within the first year with 
50-60% having some permanent disability. However, numerous gaps have been identified in 
guideline screenings and current practice patterns. Jiang et al. (2015) state that there is no 
consensus as to which menopausal or early menopausal women should have screening done via 
DXA. Often the provider is unaware as to who will manage osteoporosis screenings if a patient 
sees multiple providers or specialists. Other barriers to screening include lack of screening tools 
available, insurance, time constraints with patients, and limited availability of resources for those 
without funds. Rural health clinics face other barriers including lack of access to DXA imaging 
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and bone density testing. Consistent and preventative screenings are a must to catch those at risk 
now or deemed a future risk of fragility fracture.  
A pre-project needs assessment was explored targeting advanced practice nurse 
practitioners of the Cobb/Cherokee United Advanced Registered Nurse (UAPRN) chapter. The 
needs assessment was created and delivered by the PI in a survey format. It asked specific 
questions regarding (1) awareness of current USPSTF guidelines regarding osteoporotic 
screenings and (2) the need for an osteoporosis risk assessment workshop. Results from the 
survey indicated 33.33% of the total participants (n = 24) were not aware of current screening 
guidelines and 83.33% indicated a need for an osteoporosis risk assessment workshop.  
This paper will describe the components of a comprehensive needs assessment that was 
completed as well as the underlying rationale for choosing the topic for this scholarly research 
project. Prevention is a key component in identifying those at risk or deemed a future risk for an 
osteoporotic fracture. The needs assessment focused on osteoporosis fracture prevention as a 
phenomenon of interest. Practicing APRNs were identified due to their authorized ability to 
perform screenings and order additional imaging if warranted. The specific areas of interest 
included knowledge of current osteoporosis screening guidelines, utilization of additional 
screening tools, and practice patterns for those at risk for osteoporosis related fractures.  
Objectives and Aims 
      The purpose of this DNP translational project was to determine if the implementation 
of an osteoporotic workshop impacts the screening patterns of APRNs. Knowing in advance that 
screening rates are low for all women, the aim of the project was to empower these providers 
with tools that will identify those at risk or a future risk of either osteoporosis or a fragility 
fracture. The prevention program included an educational workshop, introduction of 
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supplemental screening tools per the World Health Organization (WHO), National Institute of 
Health (NIH), and the United States Preventive Services Task Force (/USPSTF) guidelines and 
recommendations, interpretation of BMD imaging, and advanced alternative to radiologic 
imaging devices such as ultrasound scanning.  
Rural health clinics face other barriers including lack of access to DXA imaging and bone 
density testing. The implementation of fall prevention programs is standard in assisted living 
facilities, skilled nursing homes, and community centers but rare is a program that combines a 
fall and osteoporosis prevention program (Mendis et al., 2017). The utilization of non-radiologic 
imaging tools could be a vital key in identifying those at high-risk for problems. Although 
screening recommendations exist, application and use are a valid problem. The clinical practice 
questions this project aims to answer are: 
1. Will APRN’s who attend an osteoporosis risk assessment program implement the 
SCORE tool into practice? 
2. Will the EBPQ tool identify APRN’s who will implement change into practice? 
3. What work/environmental factors are associated with the implementation of the 
SCORE tool into practice? 
4. What are the perceived barriers that prevent implementation of the SCORE tool 
into practice? 
Review of Literature 
 Osteoporosis is a major health problem and concern that affects people not only 
nationally but globally as well. As the U.S. population ages, so does the prediction in the 
increase of osteoporosis. Although evidenced based guidelines are in place to help with 
screening and treatment, osteoporosis remains underdiagnosed, undertreated, and under screened 
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(Golob & Laya, 2015). Literature is consistent that osteoporosis remains one of the most 
debilitating and chronic diseases amongst postmenopausal females with increasing risk of 
fractures after age 50 (Kling, Clarks, & Sandhu, 2014). The USPSTS warrants there is 
resounding evidence that bone mineral and measurement tests are accurate in diagnosis and 
predicting low bone mass and osteoporosis (USPSTF, 2018).   
The literature is consistent that osteoporotic fractures are associated with increased 
morbidity and mortality for numerous years after a fracture (Gillespie & Morin, 2016). There is 
also decreased quality of life, substantial medical costs, and a leading cause for disability (Rapp 
et al., 2016). Mendis et al. (2017) concluded that as many as 70%-80% of patients with an 
osteoporotic fracture are not being adequately screened, diagnosed, or treated. Patients with low 
bone mass are at high risk for current and potential future fragility fractures that will only be 
diagnosed after a fracture occurs (Keshishian et al., 2017). It is estimated that total costs related 
to osteoporosis in the US are more than $19 billion dollars and the costs are expected to rise by 
almost 50% by 2025 (Shuler et al, 2006). Health education and health promoting lifestyle 
behaviors can impact bone health. Exercise, adequate calcium intake, healthy diet, and vitamin D 
supplementation are all strategic influences that can positively impact bone mass. Genetics and a 
family history of osteoporosis can also impact bone mass in a negative way. Research promotes 
prompt evaluation, screening, and treatment of osteoporosis and is indicated to prevent further 
fracture-related conditions as well as morbidity and mortality.  
The extent to which providers follow the USPSTF guidelines in screening, specifically 
Medicare age females, is unclear but studies conclude screening rates between 30-48% 
(Amarnath, Franks, Robbins, Xing, & Fenton, 2015). Rural areas face other challenges and DXA 
imaging is negatively impacted with a 20% drop in osteoporosis screening rates when a DXA is 
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located greater than 5 miles from the patient (Shuler et al., 2016). There is inconsistent universal 
consensus as to when to begin screenings as stated by Golob and Laya (2015). The FRAX tool is 
one of the most popular yet underused tools in identifying those at risk. Conflicting decisions 
occur when providers suspect a patient could be at risk yet hesitant to screen due to unnecessary 
costs and imaging.  
Numerous non-imaging tools have been used by clinicians for decades with accurate 
specificity in results as compared to BMD imaging. The results of a phone survey on rural West 
Virginia females, 65years and greater, confirmed that the FRAX phone survey is as reliable as 
DXA in detecting osteoporosis or osteopenia but fails to identify women younger than 65 at risk 
(Shuler et al., 2016). Despite available current guidelines, research states less than 25% of 
women 65 years and older underwent bone mass screening from 2008 to 2014 (Gillespie & 
Morin, 2016). Findings are reliable that there are inconsistencies related to when to screen for 
osteoporosis in females, often leading to missed opportunities for treatment to prevent further 
bone loss. 
Risk Factors 
   Bone mineral density is associated with several factors such as age, menopause status, 
weight, body mass index (BMI), and socio-economic class (Haryono & Prastowo, 2017). 
Postmenopausal females are much higher risk than their male age equivalent counterparts. Kling 
et al. (2014) notes that the lifetime risk of any osteoporotic fracture is 40%-50% for women and 
13%-22% for men which is considerably higher than other major diseases. Risk factors include 
family history of osteoporosis, advancing  age, female gender, smoking, excessive alcohol use, 
lack of exercise, a diet low in calcium and vitamin D, thin frame or below normal body mass 
index, hyperthyroidism and hyperparathyroidism, glucocorticoid use, premature menopause, 
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post-menopausal state (estrogen deficiency), excessive dieting or eating disorders, and being of 
European or Asian descent. The use of daily dose glucocorticoids as low as 2.5mg to 7.5mg can 
significantly decrease bone density and most noted in the first few months of use (Golob & Laya,  
2015). They also note that most osteoporotic hip fractures occur due to falls and it is imperative 
to assess environmental factors that may contribute to falls such as hazards in the home, impaired 
balance and decreased proprioception, and medical conditions such as hypotension which can 
cause significant dizziness and balance issues.  
Mortality 
Currently, there are over two million osteoporotic related fractures in the United States 
annually with rates expected to increase to three million by 2025 (Gold et al, 2019). Fifty percent 
of U.S. women will experience an osteoporosis-related fracture in her lifetime with hip fractures 
being the leading cause of long-term nursing home care (Kling et al., 2014). In the Swedish 
SENIORLAB  study, osteoporosis was found to be the most important risk factor for all causes 
of mortality in a relatively healthy population of persons ages 60-99 (Gutzweller, 2018). 
Findings of this study state that a clinical diagnosis of osteoporosis had a higher relative risk for 
mortality than diabetes type 2 and hypertension.  
Literature is consistent that there is worldwide under-screening and under-treatment for 
osteoporosis. Low bone mass, left undetected, can lead to burdensome fractures and decreased 
quality of life. Mortality rates for hip fractures can be as high as 45% one-year post fracture. The 
USPSTF estimates that by the year 2020, 12.3 million individuals in the U.S are expected to 
have osteoporosis (USPSTF, 2018). The overall impact related to these fractures is often difficult 
for a person or family to manage.  
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Costs 
 The burdens and costs related to osteoporosis are seen globally. It has become a major 
U.S. health problem affecting millions of adults >50.  Falls, fractures, increased morbidity and 
mortality, hospitalizations, lost days of productivity, depression, and decreased quality of life are 
some of the most impactful consequences related to osteoporosis. It is often called the silent 
disease until a fracture occurs and thus causing significant impact on the quality of daily living 
and life. The yearly cost of osteoporotic fractures is approximately $2 billion and expected to 
increase with our aging population (Daroszewska, 2015). The majority of these costs are related 
to hip fractures and their high mortality and morbidity rates. The costs and annual fracture rates 
associated with osteoporosis are estimated to rise by 50% by the year 2025 (Kling et al., 2014).  
 Osteoporosis is one of the foremost causes of disability and morbidity worldwide in older 
adults (Rapp et at., 2016). Individuals are often left with chronic pain and disability due to these 
fragility fractures. The loss of independence associated with fractures often leads to depression, 
isolation, altered daily engagement activities, and social withdrawal. Only 50% of hip fracture 
patients regain their functional status after the fracture (Tsai, 2019).  
There are often socioeconomic factors related to the prevalence of osteoporosis as seen in 
non-citizens of the U.S. and the less educated. Osteoporosis is also more prevalent in those who 
are unemployed and with lower incomes. Individuals who rely on social security as their primary 
source of income often become food insecure and make poor food choices due to lack of income 
(Black et al., 2009). The soaring medical costs related to fracture care can leave an individual 
without adequate resources for a healthy diet and lifestyle. Post fracture care can leave an 
individual with little financial resources to live on. Difficult choices often must be made for 
long-term care or assisted living arrangements.  
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Tools 
The goal of osteoporosis screening is to identify individuals who are at increased risk for 
low bone mass and would benefit from an intervention to decrease the risk. For the purpose of 
this project “tools” will include the non-radiologic risk assessment tools/instruments that can be 
done by either the provider or the patient. Primary osteoporosis (without underlying disease) 
increases with age and impacts different races/ethnicities differently. The USPSTF found there is 
adequate evidence that risk assessment tools are moderately accurate in identifying a person’s 
risk of osteoporosis (USPSTF, 2018).  
Numerous risk assessment tools have been validated and proven effective in identifying 
younger women who are at risk for low bone mass and at risk for the development of 
osteoporosis (Golob & Laya, 2015). During the last several decades newer screening tools have 
been acknowledged and currently replace the DXA as a first step screening process in the 
younger population to reduce unnecessary radiation exposure and the burdensome costs 
associated with DXA. Three of the most validated screening tools include SCORE, OST 
(osteoporosis self-assessment tool), and ORAI (osteoporosis risk assessment instrument). These 
tools aim at identifying persons with low bone mass who should be further sent for diagnostic 
imaging. BenSedrine et al. (2000) state that screening whole populations is unreasonable and not 
necessary. The study by BenSedrine et al. (2000) on women 45 years and older (n = 4,035) 
concluded that the SCORE tool could be used with qualified confidence to exclude patients who 
should not be imaged for low bone mass. Jiang et al. (2016) explain that early DXA screening 
and when to initiate is confusing for providers and evidence is lacking. In his study the SCORE 
tool had the highest sensitivity (92%) in predicting women who were diagnosed with 
osteoporosis with DXA. In another study of 211 female patients ages 45-88 years (average age 
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57), the SCORE tool had the highest sensitivity (95.2%) in identifying women with low bone 
mass after sent for imaging (Ahmadzadeh, Emam, Rajael, Moslemizadeh, & Jalessi, 2013). Data 
from 1,279 postmenopausal women were analyzed in a study by Lydick et al. (1998) and  
indicated the SCORE prescreening tool could decrease radiologic DXA imaging by 30%.  The 
newest recommendation is to prescreen women younger than age 65 by using one of clinical risk 
assessment tools such as FRAX, OST, and SCORE (Cauley, 2018).  
One of the most widely used tools is the FRAX tool-which estimates a 10-year 
probability of either a hip fracture or other major osteoporotic fracture with or without a BMD 
score. There are more than 30 different risk factors listed on various screening guidelines. A 
FRAX score of 20% or higher for a major osteoporotic fracture or a 3% or greater score for a hip 
fracture warrants screening with the DXA scan. Golob and Laya (2015) state that some authors 
have found that there are other tools more sensitive than FRAX in identifying women with low 
bone mass.  
DXA scan 
 Dual-energy X-ray absorptiometry, DXA scan, is the noted gold standard and premium 
method for identifying a patient with osteoporosis (Gillespie & Morin, 2016). It is the preferred 
method in diagnosing osteoporosis and observing T- scores after the implementation of 
osteoporosis medications. The current USPSTF guidelines recommend screening for 
osteoporosis in women 65 years and older as well as women less than 65 years who are at 
increased risk of osteoporosis as determined by some type of a clinical risk assessment tool 
(USPSTF, 2018) when guidelines were updated at that time. However, there is no consensus on 
when to initiate a DXA screening for early post-menopausal women less than 65 years of age.  
Jiang (2016) stated in a recent major study comparing various risk assessment tools that in using 
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the USPSTF guidelines only 24% of the women with osteoporosis would need a DXA compared 
with 92% using the SCORE tool.  
 The Choosing Wisely Initiative is a campaign founded by the American Board of Internal 
Medication (ABIM) which aims to decrease unnecessary tests, medical procedures and 
treatments. (Amarnath, Franks, Robbins, Xing, & Fenton, 2015). It does support DXA imaging 
in female patients younger than 65 with known, identifiable osteoporosis risk factors. In a survey 
reported by (Amarnath et al., 2015), over 40% of women who were referred for a DXA did not 
meet guidelines for imaging.  
Education of Providers 
 It is imperative that healthcare providers are familiar with the USPSTF and other 
healthcare screening guidelines. As newer evidence from data is analyzed, healthcare practice 
changes must follow. Amrarnath et al. (2015) evaluated different screening rates amongst a 
regional healthcare system and reported that their analysis revealed misuse and overuse of DXA 
screening for women at low risk for osteoporosis. A significant barrier is that clinicians and 
providers received little support from the electronic medical record (EMR) system with regards 
to decision making on the optimal use/ordering of a DXA. Although many older patients are sent 
reminder letters to alert them when a DXA screening is due, many providers lack the decision-
making support when a younger female patient might need to be screened due to risk factors. 
 The two most primary mechanisms of fragility fractures are osteoporosis and falls (Rapp 
et al., 2016). Many rural areas lack availability for fall prevention programs. Once osteoporosis 
is detected, it is the responsibility of the healthcare team to explore optional methods to reduce 
future fragility fracture risk. It requires the coordination of care between numerous team 
members to offer a supportive approach and program plan. Exercise is one of the most effective 
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fall prevention strategies and also improves balance, muscle mass and strength, as well as bone 
strength, yet research shows that evidence is lacking on bone strength and aerobic exercise 
programs (Yoo, Jun, & Hawkins, 2010).  
Medication 
 The use of anti-osteoporosis (AOM) drugs have shown to maintain and even increase 
bone density (Balaji, 2016). Several known classes of medications are currently used to treat or 
prevent osteoporosis: bisphosphonates, monoclonal antibodies, hormone therapy, synthetic 
parathyroid hormone, and Selective Estrogen Receptor Modulators (SERM). Bisphosphonates 
and monoclonal antibody medication work by interfering with the breakdown of bone 
composition by the osteoclasts. SERM’s and estrogen medication block osteoclast activity but to 
a lesser degree. Synthetic parathyroid medications increase the production of osteoblasts-the 
cells that actually build bone matrix.    
Dr. David Slovik, an Endocrinologist at Harvard-affiliated Massachusetts General 
Hospital, stated that the rates of hip fractures in the U.S. declined mainly in part to the use of 
bisphosphonate medication and earlier screenings (Balaji, 2016). Yu et. al. (2019) examined the 
mortality rates after anti-osteoporosis medication adherence in adults at year one, three, and five 
post hip fracture. This was a population-based cohort study of over 5,000 participants in which 
one half were treated with medications and the other group were not treated. Results from the 
study concluded that survival rates were significantly higher in the “good adherence” group 
when compared to those in the non-adherence group (p < 0.0001). The mortality rates at year 
one, three and five were 8.6%, 23.7%, and 32.2% for the treated group as compared to 11.8%, 
27.8%, and 39.0%.  in the non-treated group (Xu, Lombardi, Jiao, & Banfi, 2016). The most 
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frequently prescribed medications in this study was Alendronate (57.5%), Raloxifene (19.8%), 
followed by Calcitonin (17.8%).  
A first fragility fracture is a strong predictor of a post-secondary fracture (Gillespie & 
Morin, 2016). Data collected in the FREEDOM trial showed treatment gaps in clinical practice 
to prevent secondary fractures (Palacios et al., 2015). In this study, data from the U.S. showed  
only 7-19% of patients were treated with an AOM after a first fragility fracture and similar 
under-treatment globally. In the FREEDOM trial, patients given Denosumab (monoclonal 
antibody medication) lowered the risk for secondary fragility fractures by 39% in all risk 
subgroups independent of age. Several AOMs can be given to patients with low bone mass 
(osteopenia) with repeat DXA in 2-5 years dependent upon risk factors.  
Several studies indicate that even after osteoporosis is diagnosed, there is impediment to 
treatment (Golob & Laya, 2016 and Mendis et al., 2017). In the Mendis et al. study (2017)  87 
patients, ages 55 years and older, were followed up by their provider after a low trauma fracture. 
Results from his observational retrospective study indicated 63% were not sent for bone density 
testing, vitamin D levels were not checked in 41%, and no pharmacologic therapy started in over 
63% of the patients. Barriers to treatment include lack of knowledge, lack of awareness (multi-
provider), lack of owning the responsibility for treatment, cost of therapy/medication, low rates 
of referral to specialists for osteoporosis management, and medical comorbidities.  
The current recommended guidelines when using AOMs is to treat for five years 
followed by full re-evaluation with a physical examination and repeat BMD (Golob & Laya, 
2015). At that time, if no new high-risk factors have come into play, the patient can be monitored 
closely. All patients are encouraged to get adequate sources of calcium as well as vitamin D in 
their diet. The Institute of Medicine as well as the National Osteoporosis Foundation 
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recommends 1,200mg of calcium daily for women 51 years and older and 700-1,000mg of 
vitamin D daily dependent upon age. The National Osteoporosis Foundation recommends bone 
density testing every 3-5 years after medication onset as well as possible bone turnover 
biochemical markers (National Osteoporosis Foundation, n.d.).  
Prevention 
 Literature is consistent that there is under screening for osteoporosis, lack of consistency 
in screenings, and lack of treatment initiation. The primary goal is the prevention of osteoporotic 
fractures throughout a lifetime with special attention to any female, regardless of age, who may 
have risk factors that pose a threat to optimal bone health. Prevention includes risk assessment 
screenings, bone density screenings, adequate exercise, a diet rich in calcium and vitamin D, as 
well as lowering a modifiable risk that may impede strong bone matrix.  
Prevention can begin as early as age 30 when bone density starts to decline slowly. 
Daroszewska (2015) stated that a healthy lifestyle, daily physical activity, and a diet high in 
soluble fiber increase intestinal absorption of calcium thereby increasing bone mineral density. 
In a randomized clinical trial with over 3,000 healthy, ambulatory females, those who were given 
a treatment of 800 international units (IU) of Vitamin  D daily showed a 32% reduction in 
overall fractures and a 43% decrease in hip fractures (Daroszewska, 2015). Tan, LaMontagne, 
English, and Howard (2016) did a cluster-randomized trial which compared workplace groups 
that were placed either in a control group or the intervention group. The intervention group 
received three osteoporosis prevention workshops. Comparisons were made six months after the 
intervention which showed the work-intervention group had improved calcium daily intake and 
increased load/weight bearing physical activity (p < .0005) when compared to the control group. 
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It is estimated that as much as 23% of osteoporosis is due to lack of physical activity (Tan et al., 
2016).  
Theoretical Model 
The model used for this project is the RE-AIM Framework developed by Russ Glasgow, 
Shawn Boles, and Tom Vogt in 1999 (Gaglio, Shoup, & Glasgow, 2013). The Reach,  
Effectiveness, Approach, Implementation, and Maintenance model grew from the need to 
establish validity of the implementation of healthcare promotion and the need to report key 
findings. It was originally created to assess the dissemination of clinical healthcare practice 
changes and widely used today by many key stakeholders and organizations. RE-AIM (Figure 1) 
follows a logical sequence from thought to adaptation and implantation of research to allow for 
more effective evaluation and reporting of initiatives.    
The Reach in RE-AIM is the targeted audience and represented those individuals who 
would like to participate in a new initiative. The APRNs in this project were the population that 
had been chosen as they expressed interest and need to learn about osteoporosis  screening. The 
project plans to reach the members of the Cobb/Cherokee APRNs who were actively seeing 
female patients, who ranged at least from 45-64 years of age, in their practice setting. The 
Effectiveness in RE-AIM is the impact that an intervention or initiative had on an outcome-
positive or negative. The intention for this project was the APRN’s would embrace an evidence-
based and validated tool to screen for low bone mass after presentation by the PI. The 
implementation of the SCORE tool into APRN practice was measured post project. The 
Adoption section of RE-AIM  focused on the representativeness of a group or setting who were 
willing to initiate a program. The APRNs who screened using the SCORE tool were encouraged 
to adopt the tool into practice. The Implementation of RE-AIM referred to the target groups 
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faithfulness to all elements of an initiative or intervention  protocol. The APRNs were asked to 
use the SCORE screening tool for a total of four weeks. The Maintenance portion of RE-AIM 
was the extent to which an organization validated and institutionalized the said intervention or 
imitative as part of practice. The goal of the project was to arm APRNs with additional tools to 
prescreen females for low bone mass and capture those at risk by implementing the SCORE tool 




Note. This figure demonstrates the  REAIM Framework. Reach your intended target population-
Efficacy or effectiveness- Adoption by target staff, settings, or institutions-Implementation 
consistency, costs and adaptations made during delivery-Maintenance of intervention effects in 
individuals and settings over time (Gaglio et al., 2013). 
Methodology 
The  project used an evidence-based study design to incorporate clinical expertise and the 
best scientific evidence to impact osteoporosis screening patterns in APRNs to identify women at 
risk for low bone mass. The overall purpose of this project was to increase knowledge of APRNs 
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that low bone mass and osteoporosis can be suspected at ages less than 65 using the SCORE tool.  
A comprehensive educational osteoporosis workshop was given to interested APRNs bringing 
awareness of the need to screen females ages 45-64. The project consisted of a planning phase, 
project implementation phase, and post workshop analysis phase. After post implementation  of 
the project, a descriptive analysis was completed to identify if APRNs were able to implement 
the SCORE tool into practice and identify any barriers that prevented them from doing so. 
Setting 
 The project took place at the healthcare setting where the APRN participants were 
employed. These areas included APRNs working in Primary Care/Internal Medicine, Women’s 
Health, Rural Health, or Health department. If the participant was not employed in one of these 
places, they could be employed in a different area so long as they fulfilled the requirement of 
seeing female patients 45-64 years of age. The participants could be part time, full time, or per 
diem and used the screening tool SCORE on female patients ages 45-64. The educational 
workshop was held at a local senior assisted living center for the Cobb/Cherokee UAPRN 
chapter members that expressed interest in attending. The setting included seating, an audio-
visual media center, and access to break rooms.  
Study Population 
The study participants consisted of APRNs (Cobb/Cherokee chapter) of the nursing 
organization United Advanced Practice Registered Nurses of Georgia. Participants who attended 
the workshop were asked to volunteer for this project if they met the inclusion criteria. All 
consent forms and instructions for the participants were given at the workshop. The attendees at 
the workshop were encouraged to complete the workshop even if they had no plans to participate 
in the project. Inclusion criteria included being a member of UAPRN, holding an active APRN 
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license without restriction in the state of Georgia, and current employment in Primary Care, 
Internal Medicine, Women’s Health, or Rural/County Health. The exclusion criteria included 
APRNSs who did not meet the previous stated criteria or presently using the SCORE tool in 
practice regularly.   
Project Interventions 
 The planning phase of this project included an educational osteoporosis workshop that 
preceded the start of the project phase. Upon arrival, participants checked in at the registration 
table, signed a consent form after explanation of the project by the PI (Appendix B), confirmed a 
current email address and created a personal identifier number (ID) (the first letter of their first, 
middle, and last name, and the year of birth). After participants checked in and were seated, the 
PI handed out and explained the Practice Demographic Characteristic Survey (Appendix C) and 
Evidence Based Practice Questionnaire (EBPQ) (Appendix D). Each participant was given 
instructions to place their created ID number on the top of the forms. The PI collected all forms 
and placed them in a sealed envelope along with the master list of the ID numbers and email 
addresses. Those participants who chose not to participate in the project were allowed to attend 
the osteoporosis workshop. A one-hour osteoporosis presentation was given by the PI covering 
osteoporosis, bone formation and resorption, risk factors, screenings, current guideline 
recommendations, and impact on healthcare.  During the osteoporosis workshop, the PI 
introduced the risk assessment tool called the Simple Calculated Osteoporosis Risk Estimator 
(SCORE) to be used during this project. Instructions on the use of the SCORE tool were given 
during the presentation. After completion of the workshop all attendees were asked to complete 
an evaluation of the workshop (Appendix E). The workshop evaluation summary was formatted 
using a Likert scale. It was created by the PI to determine the impact of the workshop on 
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attendees (even if they did not volunteer for the project) in the ability to comprehend the impact 
of osteoporosis on females, the need for screening, and ability to use the SCORE tool.  
 Interested APRNs who expressed desire to participate in the project were encouraged to 
implement the use of the SCORE tool into their practice for the next four weeks to their female 
patients between the ages of 45-64. The PI sent a weekly email reminding the participants to use 
the SCORE tool in practice for the next four weeks. After completion of the four-week 
timeframe for implementing the SCORE instrument, the participants were sent a link to complete 
a Post Project Implementation survey (PPIS) via Qualtrics (Appendix F). The participants were 
asked to enter their ID number that was chosen at the start of the project and include it on the 
survey. The PPIS identified whether the APRN was able to implement the SCORE tool into 
practice. If the participant was unable to implement the tool into practice they were given a 
checklist to identify barriers to implementation of the SCORE tool.  
Outcome Measures 
Several validated tools were used for this project after a complete and comprehensive 
review.  At the workshop, each subject was given the Evidence Based Practice Questionnaire 
(EBPQ) to determine their current practice patterns regarding knowledge, attitudes, and use of 
evidence-based practice in their current healthcare setting.  The EBPQ was developed by 
Professor Dominic and Dr. Penney Upton (Upton & Upton, 2006) with the sole purpose to gather 
information from healthcare professionals on their attitudes and knowledge regarding evidence-
based practice. The instrument focused on three main areas: attitudes, knowledge, and use of 
evidenced based practice. It was a 24-item questionnaire with a seven-point (1 = never and 7 = 
frequently) Likert rating scale. It’s ease of use and straight forwardness made it a desirable 
instrument to use across the various educational levels of those taking the tool. The Cronbach’s 
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alpha scores ranged from 0.70 to 0.93 (a > 0.7 to 0.93). The Practice Demographic 
Characteristics survey was an instrument created by the PI and was used to assess demographic 
and practice setting specifics of each participant. All participants who attended the workshop 
were asked to complete the survey. It consisted of eight questions with multiple choice answers. 
The Simple Calculated Risk Estimation score instrument (SCORE) (University of Washington-
Osteo ED, n.d.), is a  non-invasive and non-radiologic risk assessment tool that can play a key 
role in identifying women less than 65 years of age at risk for osteoporosis and potential future 
fractures (Pecina, Romanovsky, Merry, Kennel, & Thacher, 2016). The participants were asked 
to implement the SCORE tool into practice for four weeks. The participating APRNs were then 
emailed the Post Project Implementation Survey (PPIS)  after completion of the four-week 
SCORE tool use which will specifically measure any work/environmental factors associated with 
the implementation of the SCORE tool into practice as well as any perceived barriers that 
prevents implementation of the SCORE tool into practice. The survey was created by the PI and 
consisted of  two questions to be answered by the participants one week after completion of the 
project. 
Benefits/Risks 
 The goal of this project was to increase screening patterns of  the APRNs. There was 
negligible physical harm in attending a workshop and implementing evidence-based practice.  
The risk for the APRN was not identifying those women at risk. As with any radiologic x-ray,-a 
participant could be exposed to a small amount of radiation if the provider deemed they need to 
have a DXA scan due to their SCORE evaluation. The decision to have the DXA scan done was 
solely the decision of each patient. There could be slight stress or  psychological  harm should a 
patient score as high-risk and the DXA scan order be placed or discussed with the patient. There 
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was minimal risk for any undue physical or psychological harm, stress, or legal complications for 
the APRN’s participating in the project. Use of the SCORE tool could extend the patient visit by 
an additional 5-7 minutes. The participant may elect to opt out of the project at any time without 
any questions or explanations asking about their decision. 
Subject Recruitment 
 Recruitment for this project used the convenience sampling method of the 
Cobb/Cherokee UAPRN chapter members of United Advanced Practice Registered Nurses 
(UAPRN). The PI sent an email to the county chapter members inviting them to an osteoporosis 
workshop and recruited members to participate in the DNP project at the conclusion of the 
workshop. The email was sent four weeks before the workshop start date. Interested APRNs 
were able to click on the link in the email and confirm their plans to attend. A confirmation email 
was then sent to those APRNs who wished to attend the workshop given by the PI with a 
reminder email one week prior to the workshop. The acceptance to participate in this project was 
voluntary and subjects could opt out or discontinue participation at any time. APRNs could still 
attend the workshop should they choose not to participate in the project.  
Consent Procedures 
 After completion of the osteoporosis workshop, the PI asked for volunteers to participate 
in the project. The APRNs who expressed a desire to participate were given an informed consent. 
They were asked to fully complete it after careful review. Any questions the participants had 
were answered by the PI. The consent form addressed each area of the project. The PI provided 
and collected the signed consent forms at the workshop and placed them in a sealed, private 
envelope for safety and security measures. The PI explained to all APRNs participating that no 
coercion or undue influence would be used during this project and that they may opt out of the 
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project with no penalty. Minors were not involved in this project as the participants were 21 
years of age or older. IRB approval was  received by the respective entities prior to the start of 
the project (IRB Approval).  
Subject Costs and Compensation 
The study participants were not expected to incur any out of pocket financial costs other 
than local travel mileage to the workshop. The educational workshop for the Cobb/Cherokee 
chapter members was promoted to all active chapter members and participation in the project 
was not a requirement to attend. All workshop attendees were provided a complimentary meal by 
the PI at no additional charge. There was no other project compensation awarded to the study 
participants. The dinner workshop presentation lasted approximately 1.5 hours and the attendees 
were invited to stay an additional 15 minutes if they chose to be included in the project. The 
incentive for participation in the project was the valuable education the APRNs received in 
attending a free educational workshop on osteoporosis and its detection, as well as implementing 
evidence-based practice into their workplace. APRNs who attended the workshop each received 
a one hour continuing education unit approved by the American Academy of Nurse Practitioners 
(Appendix G) after completion of a post-workshop survey created by the PI (Appendix E). 
A weekly project reminder email and one post project survey was sent to each participant 
using their home email. The use of personal emails was used to avoid employee restrictions of 
personal email use while at work. Time commitment by the subject participants was minimal by 
only reading a short weekly email and answering several questions on the post project survey.  
Project Timeline 
 A detailed timeline for the project can be found in Appendix G. The implementation of 
the project started with the educational workshop in September 2019. Participants in the project 
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were asked to use the SCORE tool for a total of four weeks on a regular basis. One week after 
completion of the four-week SCORE tool use, the PPIS was sent to each participant to complete. 
The project’s completion date, to include all analysis and interpretation, was completed in 
January 2020.   
Resources Needed/Economic Considerations 
 There were minimal financial costs encumbered by the PI associated with the planning 
and implementation of this project. A local West Cobb-Marietta, GA senior living center offered 
the use of their facility to host the osteoporosis workshop free of charge. The venue had ample 
parking and no financial obligations for use was noted. No other charges were associated with its 
use for the project. The center provided a large room to seat all workshop attendees, a kitchen for 
meal service, restrooms, and necessary media equipment for the workshop presentation. Other 
major resources included administrative items such as meals costs of the attendees, paper, 
printed workshop handouts, and mileage associated with travel to and from the workshop. The so 
noted financial costs were paid by the PI. The UAPRN Cobb-Cherokee chapter allowed free 
web/email use of its site to deliver the invite to paid members for the project. Members of the 
Cobb/Cherokee members pay a yearly membership fee of $100 to stay active within the chapter 
to receive emails and invites to workshops and dinner programs. The post project 
implementation survey was delivered through the online Qualtrics website at no charge to the PI.  
 The creation of the CE unit by the PI followed all AANP guidelines and there was an 
additional cost by the PI to meet these guidelines and the use of the AANP logo on the CE. All 
expenses incurred were paid by the PI.  
 The results of the project were formulated into a poster which was created by the PI and 
presented at the Atlanta Unity Conference in October 2019. Costs associated with the poster 
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presentation included printing of poster, conference fees, travel to and from the conference, 
hotels fees and charges, and meals. All costs were the sole responsibility of the PI.  
Evaluation Plan 
Data Maintenance/Security 
 All participants’ privacy was maintained throughout the project. Each NP created an 
identifier number to use when reporting their results and no names or other identifying 
information was released to the PI during this project. All forms were collected at the workshop 
and stored by the PI in the PI’s locked desk in a locked personal office. The surveys completed 
via Qualtrics were stored on the PI’s computer for this project and was password specific and 
locked. No audio or video recordings were used. Data was entered weekly into the PI personal 
computer using IBM Statistics 25 SPSS and stored securely. All records, data, and identifiers 
will be stored for three years per GCSU policy and then destroyed.  No future risk of harm to 
participants is foreseen. 
Data Collection 
   There were four tools that the PI collected and interpreted for data analysis. The tools 
were completed by participants who attended the workshop and those who proceeded in the 
project. The first tool to be completed was the Practice Demographic Characteristic Survey 
(Appendix C). The demographics survey was created by the PI and addressed areas such as place 
of APRN employment, prior use of SCORE tool, description of practice setting, years of APRN 
experience, and number of providers in the practice. The second tool was the  EBPQ 
questionnaire (Appendix D). It was developed by Upton and Dominick in 2006 (Upton & Upton, 
2006) to collect data and opinions from healthcare professionals on their use of evidence-based 
practice. Answers to the questionnaire are in scale format with 1 = never, 2 = occasionally, 3 = 
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usually, and 4 = always. An explanation was given to the participants of no right or wrong 
answers and they were to answer with honest recollection as to how they currently practice. The 
first section addressed their practice in relation to individual care-how often had they done the 
following in a response to a gap in their knowledge. The second section of the EBPQ asked 
attendees to self-reflect and rate themselves concerning evidence-based practice, time 
constraints, and practice changes (Table 3). The final section addresses self-reporting of research 
and informational technology skills. The third tool was the Post Project Implementation Survey 
which addressed if the participants were able to implement the evidenced-based SCORE tool 
into their practice setting. The fourth tool was the workshop evaluation form created by the PI 
and completed by all participants upon conclusion of the presentation (Appendix E).  
The attendees were asked to complete both the demographics survey and the EBPQ prior 
to the presentation of the workshop. The PI answered any questions if they arose. The PI 
collected the completed surveys and placed them in a sealed envelope. After the four-week 
project timeframe, the participants were emailed the Post Project Implementation Survey 
(Appendix F) to complete. The PPIS was emailed to their home email as stated in the consent. 
There were 11 participants who completed the PPIS.  
Data Analysis 
Demographic Description 
 There were 24 attendees at the workshop, and 45.8% (n = 11) agreed to continue as 
participants in the project (Table 1.). After the one-hour presentation, the attendees were asked to 
complete a written workshop evaluation (Appendix E). The workshop evaluation numbers 
ranged from 1 = strongly disagree, 2 = somewhat disagree, 3 = agree, and 4 = strongly agree to 
be answered honestly after the presentation. The attendees felt the workshop was a valuable 
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experience and gained insight and knowledge on the impact of osteoporosis. The evaluations 
disclosed that 100% (n = 24) of the attendees were now better able to: (1) learn the devastating 
impact of osteoporosis on females (2) identify younger females at risk for low bone mass and (3) 
over 83% could utilize the SCORE tool to help screen younger female patients.   
Demographic data analysis was completed using SPSS IBM 25 software. The missing 
data from the EBPQ was assigned the number 99 and entered into SPSS. The majority of the 
participants (54.5%) worked in settings other than Primary Care or Internal Medicine, and most 
(90.9%) classified their place of employment as urban. The average number of years of advanced 
practice nursing was 11.6 years and ranged from 1.5 years to 43 years. Most participants worked 
with other MD’s at their place of employment (75%) with a total of 1-5 APRN’s (75%).  
 
Table 1. Demographics of APRNS’s_________________________________________________       
 
Variables      N          Percentage________ 
 
Place of employment 
 Primary Care/Internal Medicine               4   36.4% 
 Women’s Health   1    9.1%     
Health Dept.    0     0.0 % 




 Rural     10   90.9% 
 Urban       1    9.1% 
______________________________________________________________________________ 
 
Years of  Advanced Nursing practice 
 0-5      4   36.4%    
6-10      1     9.1% 
 11-20      4   36.4%       
 20+      2   18.2% 
______________________________________________________________________________ 
 
Providers in the practice setting 
 MD 
  0    2   18.2% 
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  1-5    3   27.3%    
6-10    2   18.2% 
10+    1    9.1% 
(missing entry)   3   27.3% 
 
  APRN 
  1-5    6   54.5% 
  6-10    1    9.1% 
  10+    1    9.1% 
  (missing entry)   3   27.3%   
 
 Other Provider 
  0    4   36.4%  
  1-5    3   27.3% 
  6-10    1    9.1% 
  10+    0    0.0% 




 Hospital    6   54.5% 
 Private practice    4   36.4% 
Health dept    0    0.0% 
Other     1        9.1% 
 
______________________________________________________________________________   
 
Findings of Research Questions 
Research Question 1: Will APRN’s who attend an osteoporosis risk assessment program 
implement the SCORE tool into practice? 
Findings revealed that 90.9% of the participants (n = 10) planned to continue 
incorporating the SCORE tool into practice with the intention of using it as a pre-screening 
instrument. One participant indicated that the SCORE tool would not be continued to be used, 
which was identified on the PPIS. Prior to the osteoporosis workshop, 63.6% of the participants 
reported they had no prior use of the SCORE tool. After the projects’ completion, 91% of the 
participants planned to continue using the SCORE instrument as a means to capture those 
women (ages 45-64) who might be at risk for low bone mass (Table 4). The participants who 
 
AN OSTEOPOROSIS RISK ASSESSMENT WORKSHOP  36 
 
attended the workshop stated they gained valuable evidence-based information and saw a 
definite need to prescreen younger female patients. The increase in pre-screening females will 
enable providers to initiate low bone mass education and/or medication regimens sooner. 
Patients will gain valuable instruction by the APRN on ways to increase protection of bone mass 
if screened earlier.  
Research Question #2: Will the EBPQ tool identify APRN’s who will implement change into 
practice? 
Eighty-three percent of the participants rated themselves as either “always seeing 
evidence-based research as fundamental to their practice” (n = 7) or “usually seeing evidence-
based research as fundamental to their practice”  (n = 2) out of the total 11 APRN project 
participants (Table 3). The remaining two participants rated themselves as “never seeing 
evidence-based research as fundamental to their practice” (18%). Results concluded that the 
APRNs (n = 7) who rated themselves as “always seeing new evidence as fundamental to 
professional practice” were more likely to implement change (planned to continue to use the 
SCORE tool) than those who rated themselves as “usually seeing new evidence as fundamental 
to professional practice” (n = 2). Of the two participants who “usually” saw new evidence as 
fundamental to practice, one did not plan to implement change into practice and did not state a 
specific reason.  
The results reveal that APRNs embrace evidence-based knowledge and research when 
incorporating it into their practice settings. APRNs are educated while held to the highest 
standards and expected to implement new data and information in keeping with the best interest 
of the patient. The APRNs who see new evidence as fundamental to practice will promote health 
and awareness to their patients as new data and research becomes available. APRNs are required 
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to continue to learn and keep abreast of new healthcare guidelines as they become available. 
Many patients prefer to have an APRN as their sole healthcare provider due to the diligent effort 
APRNs pour into their patients’ health promotion. 
Research Question #3: What work/environmental factors are associated with the 
implementation of the SCORE tool into practice? 
   Over 91% of the participants that planned to continue to implement the SCORE tool into 
practice were classified as working in either a hospital or private practice setting (n = 10). The 
work and environmental factors associated with implementation of the SCORE tool into practice 
disclosed both rural and urban APRNs planned to continue use of the SCORE tool (Table 4). 
One participant classified her employment setting as urban and was unable to continue its use for 
other reasons, as indicated on the PPIS. APRNs are a valuable key stakeholder when educating 
their patients.  
The results indicate that rural patients who have little or no access to radiologic DXA 
imaging can be pre-screened with a valid evidence-base tool to identify their risk for low bone 
mass. Both rural and urban APRNs can educate their female patients on ways to promote optimal 
bone mass and prevent further breakdown of skeletal mass. Baseline SCORE results can be 
tabulated and entered into the EMR and repeated as needed. The APRN can tract any changes 
over the years and proceed to order radiologic imaging if needed while protecting the patient 
from unnecessary radiation exposure.  
Research Question #4: What are the perceived barriers that prevent implementation of the 
SCORE tool into practice? 
 Over  90% of the APRNs employed in Primary Care, Internal Medicine, Women’s 
Health, Health Department, or Other were able to use the SCORE tool and planned to 
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incorporate it into their practice (n = 10). There was one participant who did have a barrier that 
prevented the use of the SCORE tool after completion of the project. The participant listed the 
barrier as “other reason” on the PPIS for explanation as to the barrier. No further information 
was given on the barrier by the participant. This participant did rate as “usually seeing new 
evidence as fundamental to professional practice.” The participant did not state if they were able 
to fully use the SCORE tool for the entire four weeks but did answer the PPIS that was emailed 
upon conclusion of the project.  
 The results indicate there are minimal barriers for APRNs to implement the SCORE tool 
into practice. This will assist many healthcare providers in their decision making with regards to 
earlier screenings.  
Further Findings 
The attendees evaluated the workshop as proven to be successful in identifying women 
whom they should screen and gained valuable education on use of the SCORE tool. Regarding 
the EBPQ, there were six questions in the first section that the participants were asked to 
complete (Table 2). Six participants (54.5%) articulated they framed an answerable question at 
the beginning of patient care to fill in knowledge gaps regarding their practice. After known gaps 
were identified, over 90% of the attendees stated they tracked down pertinent evidence once the 
question was identified and critically reviewed the literature for set criteria. Over 90% stated 
they integrated newly found evidence into their practice once identified, and 72.% shared this 
information with peers/colleagues. After researching and filling knowledge gaps, 72.8% (n = 8) 
stated they evaluated the outcomes of their practice changes.         
 In the second set of questions of the EBPQ (Table 2), the first question addressed 
allotting time to incorporate new evidence into practice. Findings indicated 72.7% (n = 8) did 
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make time in their schedules. Only 9% (n = 1) stated they never made time for new evidence 
regarding their work schedules. Over 90% (n = 9) welcomed questions about their clinical 
practice patterns. Results showed that 81.5%  usually or always deemed evidence-based practice 
as fundamental to their practice, with 54.5% (n = 6) claiming that their practice has changed 
because of new evidence they have found and incorporated. Only one participant stated their 
practice had not changed because of new evidence being found. There was no further 
information given to the PI regarding why they chose or were unable to continue to use the 
SCORE tool.  
_____________________________________________________________________________________________ 
Table 2. Evidence-Based Practice Questionnaire (EBPQ) 
 
Questions           Never            Occasionally           Usually            Always 
         n (%)             n (%)  n (%)             n (%)_____________ 
 
Considering your practice in relation to an individual patient’s care over the past year how often 
have you done the following in response to a gap in your knowledge  
 
Formulated a clearly 
answerable question as         1 (9.1%)        2 (18.2%)              6 (54.5%)               2 (18.2%) 
the beginning of the 




Tracked down the relevant        0 (0%)         1 (9.1)  8 (72.7%)   2 (18.2%) 
evidence once you have 
formulated the question: 
 
 
Critically appraised, against       0 (0%)        1 (9.1%)  8 (72.7)    2 (18.2) 
set criteria, any literature 
you have discovered: 
 
 
Integrated the evidence you        0 (0%)         1 (9.1%)  7 (63.6%)   3 (27.35) 
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_____________________________________________________________________________  
Table 3.  Evidence-Based Practice Questionnaire (EBPQ) 
 
Questions               Never            Occasionally           Usually            Always 
      n (%)             n (%)       n (%)      n (%) 
______________________________________________________________________________ 
 
Please indicate how you would place yourself for each of the following questions. 
 
I make time for new           1 (9.1%)  2 (18.2%)        6 (54.5%)          2 (18.2%) 




I welcome questions           1 (9.1%)                 1 (9.1%)         4 (36.4%)               5 (54.5%) 




Evidence-based medicine    2 (18.2%)    0 (0%)               2 (18.2%)               7 (63.3%) 




My practice has                    1 (9.1%)                1 (9.1%)                     3 ( 27.3%)             6 (54.5%) 
changed because of 
evidence I have found: 
_____________________________________________________________________________________________ 
 
   
The project participants scored themselves on their prior use of the SCORE tool before 
the project and after project implementation (Table 4.). Prior to the workshop, 63.6% (n = 7) of 
the participants indicated they had not previously used the SCORE tool. Only 36.4% (n = 4) had 
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_____________________________________________________________________________________________ 
Table 4. (n = 11) 
 
SCORE tool use prior to workshop_________________________________________________ 
 Frequency (n) Percent (%) 
0 times 7 63.6% 
1-5 times 4 36.4% 




SCORE tool use after project______________________________________________________ 
 Frequency (n) Percent (%) 
No-will not use 1 9.1% 
Yes-will use 10 91.9% 
Total                       11                   100% 
   
 
Recommendation and Discussion 
 The USPSTF guidelines and recommendations regarding screenings for osteoporosis 
prove valid and necessary. However, literature is consistent that many younger females are at 
risk for low bone density, and healthcare providers are missing opportunities to screen before age 
65. The potential to decrease future fragility fractures is overwhelmingly necessary and 
imminent (Golob & Laya, 2015). The PI recommends that APRNs continue to use the SCORE 
tool for screening younger female patients. The project highlighted the inconsistencies of 
screenings and the need for more global awareness of this overwhelming problem. Education for 
healthcare providers is imperative to incorporate evidence-based research into practice. The PI 
found valuable awareness and current preventative screening information from the USPSTF 
website.   
Economic/Cost Benefit 
 The goal of osteoporosis screening is to identify women with lower T-scores (<2.5) so 
that appropriate therapy can be initiated and the prevention and/or reduction of potential 
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fractures. Data shows that 50% of postmenopausal females will experience an osteoporotic 
fracture in her lifetime, and over 200 million women worldwide will be affected by osteoporosis 
(Daroszewska, 2015). Although to date there are valid risk assessment tools and radiologic 
imaging tests available to identify risk for osteoporosis or confirm diagnosis thereof, Gillespie 
and Morin (2017) state screening among women ages 50-64 has declined steadily from 2008-
2014. Osteoporotic related fractures in the U.S. cost approximately $17 billion annually and are 
expected to continue to rise as our population ages (Gold et al., 2019). It is estimated that 
osteoporotic fractures lead to more than 500,00 hospital admissions annually and account for 
greater than 800,000 hospital emergency room visits (Gold et al., 2019). The effect and costs 
associated with osteoporosis are also impacted by the burden of non-direct medical costs such as 
pain, depression, and poor health. Many women are left to reside in assisted rehabilitation 
facilities and suffer from chronic pain and altered function of life. For many patients, the quality 
of life is severely impacted, leading to social isolation and mental health challenges. The benefit 
of identifying women at risk for low bone mass can prevent future fractures and possibly 
mortality. Literature is consistent, stating that morbidity and mortality rates are high post-
fracture, with 20%-25% of hip fracture patients dying after the first year (Tsai, 2019).  
Pharmacological and nonpharmacological interventions are available to increase bone 
density to prevent further bone loss. The SCORE risk assessment tool has a high sensitivity in 
predicting those females with low bone density and providing healthcare providers an extra tool 
to assist with decisions in treatment and further testing. APRNs are in an excellent position to 
teach and educate their patients.  
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Impact on Healthcare Quality and Safety 
 The screening and diagnosis of osteoporosis do not lie in the hands of any one particular 
healthcare member. The confusion often evolves when patients see varying specialists and 
healthcare team members for treatment and observation. Providers might assume a specialist is 
providing the screening when, in reality, no screening has been attempted. The SCORE risk 
assessment tool is validated as a safe, nonradiologic instrument that helps identify women at risk 
for low bone mass. It does not replace the DXA scan-but optimally excludes patients who should 
or should not have radiologic imaging. The tool itself takes no longer than one to two minutes to 
implement with immediate results viewable. Several websites that provide free online access to 
the SCORE tool with results. There is no training necessary for implementing the SCORE tool. 
The results of each person’s SCORE outcomes identify them at either low, moderate, or high risk 
for low bone mass with 92-95% sensitivity (Pecina, Romanovsky, Merry, Kennel, & Thacher, 
2016). Reduction in preventable fragility fractures is a necessary healthcare quality control 
outcome.  
Policy Implications 
 Pecina et al. (2016) state that the SCORE tool had a statistically higher sensitivity 
threshold in detecting osteoporosis in women ages 50-64 than the current USPSTF guidelines 
using FRAX threshold of 9.3%. The SCORE tool, if implemented into a hospital or practice-
based setting, could be used as a first-line risk assessment screening instrument for younger 
female patients. EMR’s have important screening instruments embedded within the chart. 
Educating healthcare personnel to utilize the SCORE tool would help in the decision-making 
process of when to start or refer for radiologic DXA screening if low bone mass is suspected. 
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The providers would still fully appreciate the USPSTF’s guidelines for initial DXA screening at 
age 65 without any disruption in national recommendations or policy.  
Translation 
 The response upon conclusion of the workshop was positive and beneficial. Attendees 
asked numerous questions and expressed sincere gratitude for the newly learned content and 
value of capturing low bone mass early. There were numerous attendees who expressed interest 
in learning more about the SCORE tool and planned to share this information with coworkers 
and peers. Numerous attendees who did not meet inclusion criteria for participation also found 
value in attending the workshop and use of the SCORE tool.   
 Pre-screening tools have proven to be a valid and necessary instrument that will help the 
APRN in decision-making strategies with regards to DXA imaging. The majority of the 
attendees at the workshop planned to make changes within their own practice and lifestyles to 
reduce the possibility of low bone mass and fragility fractures. APRNs have a prominent place in 
both the healthcare and academic setting. The gainful information learned in this project can be 
shared with colleagues and peers.  
Limitations 
 There were several limitations the PI concurred during the implementation of this project. 
The primary limitation was the small sample size of participants. The objective was to have at 
least thirty participants volunteer for the project. The PI assumes that the small sample size was 
due to the workshop held at a location the Cobb/Cherokee chapter typically does not use for 
presentation. However, the venue chosen was appreciated by those who attended. Several student 
Cobb/Cherokee chapter members who attended the workshop were enthusiastic to start using the 
SCORE tool. However, they did not meet the inclusion criteria to be part of the project.  A 
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limitation was a small amount of missing data information from several participants on the 
EBPQ. At the beginning of the workshop, all attendees were asked to complete the EBPQ 
completely; however, three attendees missed several areas for completion. Any missing data was 
handled by assigning the number 99 and entered into SPSS. The majority of all data was 
captured and entered into the specific variable categories.  
Discussion 
 The awareness to implement this project started after the PI witnessed discrepancies in 
practice patterns of APRNs in screening for osteoporosis in their places of employment. After 
discussion with numerous APRNs regarding their initiation of screening for younger women, the 
PI saw the need for this evidence-based project. Many of the APRNs who were questioned about 
their screening patterns stated they used the FRAX tool for their older patients but lacked 
knowledge on screenings with other evidence-based non-radiologic tools. The PI did not find any 
other completed DNP or other research projects addressing the use of non-radiologic screening 
tools for younger female patients at risk for low bone mass in numerous repositories.  
 The PI was able to interview the APRNs who attended the osteoporosis workshop after 
its completion. The discussion regarding the workshop was overwhelmingly positive and 
appreciated by all who attended. Many of the APRNs voiced sincere appreciation for the new 
material learned as they had not recognized the devastating impact of osteoporotic fractures and 
their need to address earlier screenings for younger female patients. This evidence-based project 
was different from others in the respect that it provided the background of an economic and 
burdensome disease (osteoporosis) and followed with a valid screening instrument that can be 
used by any healthcare member if applied. The PI was also able to assess the APRNs self-rated 
scores on the EBPQ and input that data into the final results of this project.  
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 The PI carefully examined the literature for project needs and validity. The PI found 
sufficient need for the project-based upon literature review and APRN feedback. The consensus 
of the literature on when to screen younger female patients coincided with the APRN’s responses 
on the pre-project survey in which 33% (n = 8) did not know the current screening guidelines. 
The participants voiced appreciation and confidence in understanding their role as providers to 
use the SCORE tool as a pre-screening instrument. Those who attended the workshop expressed 
gratitude in learning of the impact of osteoporosis and screening patients.  
Dissemination 
 After the four-week use of the SCORE tool, the PPIS form was emailed to all participants 
via Qualtrics platform delivery system. The PI then gathered project data results and input those 
results into SPSS. The participants were notified of the results of the project in a post-project 
email. The email included aggregate data regarding evidence-based changes the participants plan 
to make in using the SCORE tool in their practice setting. No personal information was included 
in the aggregate data results. Results of the project were shared with the Cobb/Cherokee UAPRN 
members. 
Professional Reporting 
 The PI submitted a poster abstract to the 2019 Unity Conference committee poster chair. 
The abstract included the required specifications and met all criteria. The PI was notified three 
weeks later that the abstract had been accepted by the conference committee. Permission to 
display the project poster was granted, and the PI was notified via email that the poster could be 
displayed. The PI completed a two-day project poster presentation at the 2019 Unity Conference 
held in Atlanta, GA. The PI was available to participants at the Unity Conference for questions 
or explanations.  
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Evidence-based practice is ever changing and noted to be one of the most influential 
factors in the decision-making process. The PI plans to publish the results of the project in one of 
several nurse practitioner journals. The goal of this project was to improve screening patterns by 
APRNs of their younger female patients. Results from the project indicated the evidence-based 
and validated screening tool SCORE could be used as part of the APRNs screening patterns due 
to the success of the project.  
PI Recommendation 
 The goal of this project was to bring awareness of a need to screen younger females at 
risk for low bone mass. Research supports the literature findings that osteoporosis screenings in 
females are inconsistent, and providers lack consistent methodologies in doing them. The 
inconsistent screenings were noted nationally as well as globally (Gillespie & Morin, 2016). The 
ultimate result is to capture and pre-screen younger females who might be at risk and prevent 
future fractures. The evidence is consistent that lifestyle changes, medication, exercise, and 
dietary supplements can reverse bone loss and increase bone matrix. The recommendation and 
findings of this project by the PI are to incorporate nonradiologic pre-screening tools into the 
APRN student curriculum and increase awareness of the devastating impact of osteoporosis. The 
project workshop increased significant awareness to each individual who attended. The APRNs 
who proceeded to use the SCORE tool will now be able to accurately identify younger females at 
risk for low bone mass by using an evidence-based pre-screening tool.  
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Figure 1.  RE-Aim Model 
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Appendix A 
Simple Calculated Osteoporosis Risk Estimation (SCORE) 
Criteria: 
A. Race not black:     5 points 
B. Rheumatoid Arthritis:    4 points 
C. Fracture after age 45 of wrist, hip or rib:  4 points per fracture 
D. Age over 65:      Calculate 3 x 1st digit of age (example age 
                  70 = 21points) 
E. Weight:      Calculate -1 x weight in pounds/10  
      (example weight of 200 pounds= -20 points) 
F. Estrogen therapy never used:    1 point______________________________ 
_______ Total points 
 
 
SCORE Total:  
16-50 Points: High Risk 
7-15 Points: Moderate Risk 
0-6 Points: Low Risk 
Notes: 
Interpretation 
A. Score of 6 or above is associated with T-Score below -2 (osteopenia/low bone mass) 
B. Osteoporosis testing with DEXA Scan is recommended if Score of 6 or above 












(Osteoporosis Awareness Screening Program) 
 
I, _________________________________________________, agree to participate in the research {Osteoporosis 
Program}, which is being conducted by Linda Gay DNP-S, who can be reached at lindalgay@gmail.com/6780-231-
5218. I understand that my participation is voluntary; I can withdraw my consent at any time. If I withdraw my 
consent, my data will not be used as part of the study and will be destroyed. 
 
The following points have been explained to me: 
 
1. The purpose of this study is to identify females (45-64 years of age) who may be at hi-
risk or higher than normal risk in developing osteoporosis. 
2. The procedures are as follows: you will be asked to: 
a. Attend the Osteoporosis Program 
b. Sign the informed consent 
c. Become familiar with the SCORE risk assessment tool 
d. Offer the SCORE risk assessment tool to your female patients (ages 45-64) 
e. Complete the daily tally forms and place in a locked area    
3. Your name will not be connected to your data. Therefore, the information gathered will 
be confidential. Only the Principal Investigator will have access to the master list of ID 
numbers and data. Your information will be stored in a locked box and/or a password 
protected computer in the Principal Investigators locked office at home.  
4. You will be asked to sign two identical consent forms. You must return one form to the 
investigator before the study begins, and you may keep the other consent form for your 
records. 
5. This research project is being conducted because of its potential benefits, either to 
individuals or to humans in general. The expected benefits of this study include 
identifying younger women at risk for osteoporosis. 
6. You are not likely to experience physical, psychological, social, or legal risks beyond 
those ordinarily encountered in daily life or during the performance of routine 
examinations or tests by participating in this study. 
7. Your individual responses will be confidential and will not be released in any 
individually identifiable form without your prior consent unless required by law. 
8. The investigator will answer any further questions about the research should you have 
them now or in the future (see above contact information). 
9. In addition to the above, further information, including a full explanation of the purpose 
of this research, will be provided at the completion of the research project on request. 
10. By signing and returning this form, you are acknowledging that you are 18 years of age 
or older.   
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Signature of Participant Date 
 
 
Research at Georgia College involving human participants is carried out under the oversight of the Institutional 
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Appendix C 
Practice Demographic Characteristic Survey 
 
Participant ID number:________________ 
Please answer the following questions (circle your answer). 
 
1-APRN place of employment:  
a. Primary Care/Internal Medicine      
b. Women’s Health        
c. Health  dept. 
d. Other (please describe) ________________________                        
 
2-In the past month how often have you used a non-radiologic risk assessment tool to screen for 
osteoporosis in your pt. population?  
a. 0 times       
b. 1-5 times     
c. 6-10 times   
d. >10 times    
 
3-In the past month how often have you used the SCORE osteoporosis risk assessment tool in 
your patient population? 
a. 0 times 
b. 1-5 times 
c. 6-10 times 
d. > 10 times 
 
4-In the past month how often have you ordered a DEXA scan to screen for osteoporosis in your 
patient population?   
a. 0 times 
b. 1-5 times 
c. 6-10 times 
d. > 10 times 
 
5-Your practice setting would be considered: 
a. Urban - (urbanized areas of 50,000 or more people or urban 
clusters of at least 2,500-50,000 people0 
b. Rural – (all population, housing, and territory not included 
within an urban area) 
 
6-Enter number of years of Advanced Nursing Practice: 
a. ______________  
 
 
7- How many providers are in your practice? 
a. __________# of MD’s 
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b. __________# of APRNs 
c. __________ Other  
 
8. How would you describe your practice setting: 
a. Hospital practice 
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Appendix D 
Evidence Based Practice Questionnaire (EBPQ).  
 
This questionnaire is designed to gather information and opinions on the use of evidence based practice 
amongst health professionals. There are no right or wrong answers for we are interested in your opinions 
and your own use of evidence in your practice.   
 
1.  Considering your practice in relation to an individual patient’s care over the past year, 
how often have you done the following in response to a gap in your knowledge (please √ 
or X): 
 
Formulated a clearly answerable question as the beginning of the process 
towards filling this gap: 
Never        Frequently 
 
Tracked down the relevant evidence once you have formulated the question: 




Critically appraised, against set criteria, any literature you have discovered: 




Integrated the evidence you have found with your expertise: 




Evaluated the outcomes of your practice: 




Shared this information with colleagues: 





2. Please indicate (by √ or X) where on the scale you would place yourself for each of the 
following pairs of statements: 
My workload is too great for 
me to keep up to date with 
all the new evidence 
       New evidence is so 
important that I make the 
time in my work schedule 
I resent having my clinical 
practice questioned 
       I welcome questions on my 
practice 
Evidence based practice is 
a waste of time 
       Evidence based practice is 
fundamental to professional 
practice 
I stick to tried and trusted 
methods rather than 
changing to anything new 
       My practice has changed 
because of evidence I have 
found 
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3. On a scale of 1 to 7 (with 7 being the best) how would you rate your: 
Please circle one number for each statement 
 Poor        Best 
Research skills 1 2 3 4 5 6 7 
IT skills 1 2 3 4 5 6 7 
Monitoring and reviewing of practice skills 1 2 3 4 5 6 7 
Converting your information needs into a research 
question 
1 2 3 4 5 6 7 
Awareness of major information types and sources 1 2 3 4 5 6 7 
Ability to identify gaps in your professional practice 1 2 3 4 5 6 7 
Knowledge of how to retrieve evidence 1 2 3 4 5 6 7 
Ability to analyse critically evidence against set 
standards 
1 2 3 4 5 6 7 
Ability to determine how valid (close to the truth) the 
material is 
1 2 3 4 5 6 7 
Ability to determine how useful (clinically applicable) 
the material is 
1 2 3 4 5 6 7 
Ability to apply information to individual cases 1 2 3 4 5 6 7 
Sharing of ideas and information with colleagues 1 2 3 4 5 6 7 
Dissemination of new ideas about care to 
colleagues 
1 2 3 4 5 6 7 
Ability to review your own practice 1 2 3 4 5 6 7 
 
4. Finally, some information about you: 
 
Your profession:    Year qualified:   
 
Your position/grade:    Your speciality:   
 
Please circle the most appropriate answer as it concerns you: 
 
Your sex:   Male  Female 
 








AANP CE Activity Evaluation 
Activity Title: Identifying Females at Risk for Osteoporosis and Low Bone Mass Using a Non-
Radiologic Screening Tool (SCORE)  
 
Activity ID # 5396033609        Date: September 4th, 2019      Location: Sterling Estates of West 
Cobb 
 
Circle the number that best fits your evaluation of this activity: 
4=strongly agree  3=agree  2=somewhat disagree  1=strongly disagree 
 
 
1. As a result of my participation in this activity, I am better able to: 
a.  Learn the devastating impact of osteoporosis on females                    4      3      2      1      
 
b.  Identify younger females at risk for low bone mass         4      3      2      1 
 
c.  Utilize non-radiologic screening tools to help screen female patients  4      3      2      1 
 
 
2. The following speaker demonstrated experiential knowledge of the topic. 
a. Linda Gay                4     3      2      1 
 
3. The content provided a fair and balanced coverage of the topic.         4     3      2      1 
 
4. The content was free of commercial bias.            4      3     2      1 
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Appendix F 




Please answer the following questions. 
 
 
1-Was the SCORE tool implemented into your practice setting after attending the evidenced -based 
osteoporosis workshop? 
 ____Yes  
 ____ No (if no please proceed to question #2) 
 
 
2-If you did not implement the SCORE tool into your practice setting what barriers prevented 
you from doing so: (you may select more than one) 
____ Time constraints 
____ Practice policies 
____ Alternative screening tools 
____ Lack of evidence 
____ Lack of support from MD’s 
____ Lack of support from APRN’s 
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August 14, 2019  
 
Linda Gay 
147 Threechop Drive 




The continuing education activity “Educational workshop: Identifying Females at Risk for Low 
Bone Mass Using a Non-Radio-logic Screening Tool (SCORE)”, sponsored by Linda Gay, is 
approved for continuing education by the American Association of Nurse Practitioners. Activity 
ID number 19073804 has been assigned to this application. All sessions are approved as 
submitted.  This activity has been approved for 1 year (through August 31, 2020), provided no 
changes are made.  
 
This activity may be repeated 1 additional time within the approval year with appropriate 
notification per the AANP Accreditation policy. 
 
Use the following statement in your literature to indicate the maximum credit one person can 
obtain upon completion of this activity: “This activity is approved for 1.5 contact hour(s) of 
continuing education by the American Association of Nurse Practitioners. Activity ID 19073804. 
This activity was planned in accordance with AANP Accreditation Standards and Policies.” 
 
This approval is for the continuing education activity listed in the original application. With this 
approval, ALL changes to this program must be reported to the AANP for review as soon as they 
are identified.  This includes, but is not limited to: 
  
• session drops/additions 
• speaker changes  
• objective changes 
• date and /or venue changes 
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Any changes to content or speakers that are not reviewed by the AANP are not approved for 
credit.   
 
Refer to this activity’s ID number with all communication pertaining to this application 
including the required post-activity reports.  Attendance sheets and evaluation summaries are due 
to AANP one month after the activity’s initial presentation (no later than October 4, 2019). 




























Institutional Review Board 





TO: Linda L. Gay 
FROM: Sallie Coke, Ph.D., APRN, BC Chair of Georgia College Institutional Review Board 
PROJECT TITLE: #11983 Implementation of an osteoporosis workshop for APRN’s to identify 
female patients at risk for low bone mass 
ACTION: DETERMINATION OF EXEMPT STATUS 
DECISION DATE: 2019-07-11 
REVIEW CATEGORY: Exempt 
 
Thank you for submitting an application to the Georgia College IRB for the above-referenced 
project. Based on the information you provided in your submission, IRB has determined that 
your project involving human subjects qualifies for EXEMPT status under 45CFR part 46 
commonly known as the Revised Common Rule 2018. 
 
Assignment of exempt status to this project means that this project is exempt from further IRB 
review. This exempt status is valid unless substantive revisions to the study design occur which 
would alter the risk to participants. If a substantive change is anticipated, you may submit an 
extension/modification form detailing these changes. Please consult the GC IRB if you have a 
question about a potential change to your exempt study. 
 
Please note that all responsibilities required of conducting human subject research still apply to 
this project. Specifically, the Belmont Report principles of respect for persons, beneficence, and 
justice apply, and all investigators involved in this project must have and maintain current/valid 
certification of training with conducting research with human subjects 
 
We will retain a copy of this correspondence within our records. 
 
If you have any questions, please contact irb@gcsu.edu. Please include your project title and 
reference number in all correspondence with this committee. 
This letter has been electronically signed in accordance with all applicable regulations, and a 




Sallie Coke, Ph.D., APRN, BC 
 
